1-(2-chloroethyl)-5-methyl-1H-pyrazole-4-carbaldehyde, 95.0%, 25g

((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate, 97%, 10g

Methyl 2,4-dichloro-5-pyrimidinecarboxylate, 97.0%, 5g

Imidazo[1,2-a]pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]-, 1g

1-Oxaspiro[2.5]octane-2-carbonitrile, 97.0%, 5g

4-Chloro-2-(methylthio)pyrimidine-5-carboxylic acid, 95.0%, 10g

1,4-Bis(2-chloroethyl)piperazine, 95.0%, 5g

2-Amino-5-formyl-3-methylbenzoic acid, 95.0%, 1g

Cuvette monouso PMMA, Macro, da 2,5 a 4,5 ml, 100 Pezzo(i)

2-Methyl-4-pyrimidinamine, 98.0%, 10g

(S)-2-N-Fmoc-aminomethyl pyrrolidine hydrochloride, 98.0%, 5g

2-(3,5-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)1g

(3-Bromophenyl)(imino)(methyl)-lambda6-sulfanone, 98%, 1g